S. Minton

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

Pamela N. Münster, Douglas C. Marchion, Scott Thomas et al. · British Journal of Cancer · 2009 · 166 citations · Full text

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 131 citations · Full text

Difference Between Latiglutenase, Villous Atrophy, Clinical Presentation +3

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 94 citations · Full text

Obesity, Metabolic Syndrome, Camellia-timi 61 +9

Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: A randomized trial using the GnRH agonist (triptorelin) during chemotherapy

Roohi Ismail‐Khan, S. Minton, Catrin Cox et al. · Journal of Clinical Oncology · 2008 · 53 citations

Reproductive Sciences, Breast Oncology, Reproductive Health +23

RETRACTED ARTICLE: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer

Xiangqian Zheng, Jian Guo, Hua Yang et al. · Oncogene · 2013 · 38 citations · Full text

Tumor Biology, Systems Biology, Oncology +11